Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Minerva Pediatrica
|
April 28, 1976
[Massive intracranial calcifications in a newborn infant with cytomegalic disease]
G Sabatino, M Midulla, A M Bartolomei, et al.
Tissue Antigens
|
March 1, 1977
Interference between anti-HLA antibodies and adrenergic receptor-binding drugs
R Scorza-Smeraldi, E Smeraldi, G Fabio, et al.
Biological Psychiatry
|
June 15, 1990
EEG power spectrum profile and structural CNS characteristics in schizophrenia
O Gambini, C Colombo, F Macciardi, et al.
Journal of Affective Disorders
|
June 28, 2001
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users
C Turrina, A Fiorazzo, A Turano, et al.
Biological Psychiatry
|
June 1, 1979
3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations
E Sacchetti, E Allaria, F Negri, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1982
Is urinary MHPG a real predictor of drug response in primary depression?
C L Cazzulo, E Sacchetti, E Allaria, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 8, 2005
Direct transition to long-acting risperidone--analysis of long-term efficacy
W Kissling, S Heres, K Lloyd, et al.
Journal of Food Science
|
May 4, 2011
Wild Mediterranean plants as traditional food: a valuable source of antioxidants
Paola Vanzani, Monica Rossetto, Veronica De Marco, et al.
Schizophrenia Research
|
March 30, 2001
Cytokine profiles in drug-naive schizophrenic patients
C L Cazzullo, E Sacchetti, A Galluzzo, et al.
The Pharmacogenomics Journal
|
February 10, 2016
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
E Sacchetti, C Magri, A Minelli, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Minerva Pediatrica
|
April 28, 1976
[Massive intracranial calcifications in a newborn infant with cytomegalic disease]
G Sabatino, M Midulla, A M Bartolomei, et al.
Tissue Antigens
|
March 1, 1977
Interference between anti-HLA antibodies and adrenergic receptor-binding drugs
R Scorza-Smeraldi, E Smeraldi, G Fabio, et al.
Biological Psychiatry
|
June 15, 1990
EEG power spectrum profile and structural CNS characteristics in schizophrenia
O Gambini, C Colombo, F Macciardi, et al.
Journal of Affective Disorders
|
June 28, 2001
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users
C Turrina, A Fiorazzo, A Turano, et al.
Biological Psychiatry
|
June 1, 1979
3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations
E Sacchetti, E Allaria, F Negri, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1982
Is urinary MHPG a real predictor of drug response in primary depression?
C L Cazzulo, E Sacchetti, E Allaria, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 8, 2005
Direct transition to long-acting risperidone--analysis of long-term efficacy
W Kissling, S Heres, K Lloyd, et al.
Journal of Food Science
|
May 4, 2011
Wild Mediterranean plants as traditional food: a valuable source of antioxidants
Paola Vanzani, Monica Rossetto, Veronica De Marco, et al.
Schizophrenia Research
|
March 30, 2001
Cytokine profiles in drug-naive schizophrenic patients
C L Cazzullo, E Sacchetti, A Galluzzo, et al.
The Pharmacogenomics Journal
|
February 10, 2016
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis
E Sacchetti, C Magri, A Minelli, et al.
Page
of 7